| Structure |
Chemical Name |
CAS |
MF |
 |
Sitagliptin EP Impurity 6 |
|
|
 |
Vonoprazan-005 |
2514735-09-0 |
C33H27F3N4 |
 |
D-erythro-Hexonic acid, 6-S-2-benzothiazolyl-2,4-dideoxy-6-thio-, 1,1-dimethylethyl ester |
1469771-46-7 |
C17H23NO4S2 |
![(1R,2R,4S,5S,7s,9R)-9-butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide](/) |
(1R,2R,4S,5S,7s,9R)-9-butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide |
|
|
 |
1-Demethyl Hydroxy Daunomycinone |
58199-98-7 |
C20H16O9 |
 |
(S)-2-(butylsulfonamido)-3-(4-(4-(1-methylpiperidin-4-yl)butoxy)phenyl)propanoic acid |
1631053-75-2 |
C23H38N2O5S |
 |
FEXOFENADINE EP IMPURITY A - HCl |
153439-43-1 |
C32H38ClNO4 |
![2-[(4-Chloro-3-Methyl-2-Pyridinyl-methyl)thio]-1H-Benzimidazole](/CAS/GIF/103312-62-5.gif) |
2-[(4-Chloro-3-Methyl-2-Pyridinyl-methyl)thio]-1H-Benzimidazole |
103312-62-5 |
C14H12ClN3S |
 |
Pazufloxacin |
127046-18-8 |
C18H19FN2O4 |
 |
Vinpocetine |
80038-06-8 |
C22H26N2O2 |
 |
7-(but-2-yn-1-yl)-8-(3-(hydroxyimino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione |
1297273-94-9 |
|
 |
Isavuconazole Impurity 35 |
|
|
 |
Brivaracetam Impurity 26 HCl |
|
|
 |
Brivaracet amoxidation Impurity 1 |
|
|
 |
Rosuvastatin EP Impurity G Complete Set |
|
|
 |
Bortezomib Impurity G Complete Set |
|
|
 |
Peramivir Diacetyl Impurity |
|
|
 |
Peramivir Chlorisomeric Impurity |
|
|
 |
Canagliflozin impurities 15 drops |
|
|
 |
Pemetrexed Impurities 41-45 |
|
|
 |
Pemetrexed Disodium EP Impurity 999 |
|
|
 |
Bumetanide Impurity 999 |
|
|
 |
Canagliflozin Impurity 998 |
|
|
 |
N,N-dimethyl-1,4,8,11-tetraazacyclotetradecane-1-sulfonamide |
|
|
 |
Tamsulosin EP Impurity C (Desethoxy Tamsulosin) |
|
|
 |
Cefazolin Epimer Cefazolin Impuirty M (USP), Cefazolin Impurity L (EP) |
|
|
 |
Relugolix Impurity 66 |
2591260-06-7 |
C25H24F2N2O6S |
 |
methyl 3-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)-3- oxopropanoate |
|
|
![methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate](/CAS/20210305/GIF/2469735-68-8.gif) |
methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate |
2469735-68-8 |
C15H15NO5 |
![Pregn-4-ene-3,20-dione, 9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11β,16α)-](/CAS/20211123/GIF/3093-36-5.gif) |
Pregn-4-ene-3,20-dione, 9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11β,16α)- |
3093-36-5 |
C24H33FO5 |
![2-(3-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile](/CAS/20211123/GIF/2402776-84-3.gif) |
2-(3-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile |
2402776-84-3 |
C23H27N9O4S2 |
![Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[(aminocarbonyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-](/CAS/20210305/GIF/2597901-48-7.gif) |
Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[(aminocarbonyl)amino]-2-hydroxy-, (1S,2S,3R,4R)- |
2597901-48-7 |
C15H27N3O5 |
 |
3-Isoquinolinecarboxylic acid, 7-(4-chlorophenoxy)-4-hydroxy-, methyl ester |
2711953-58-9 |
C17H12ClNO4 |
 |
(2-(2-((tert-butoxycarbonyl)(methyl)amino)-N-methylacetamido)pyridin-3-yl)methyl N-(tert-butoxycarbonyl)-N-methylglycinate |
|
|
 |
Benzoic acid, 3-(aminosulfonyl)-2,4-dichloro- |
1870323-25-3 |
C7H5Cl2NO4S |
![Benzeneacetamide, N,α,α-trimethyl-N-[6-(4-methyl-1,4-dioxido-1-piperazinyl)-4-(2-methylphenyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)-](/CAS/20210305/GIF/1431216-61-3.gif) |
Benzeneacetamide, N,α,α-trimethyl-N-[6-(4-methyl-1,4-dioxido-1-piperazinyl)-4-(2-methylphenyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)- |
1431216-61-3 |
C30H32F6N4O3 |
 |
Tafluprost Impurity 15 |
|
|
 |
Rosuvastatin Impurity 159 (Sodium salt) |
|
|
 |
Rosuvastatin Impurity 140 |
|
|
 |
Rosuvastatin Impurity 130 |
|
|
 |
Terlipressin Impurity 1 (des-Gly1) |
|
|
 |
Brivaracetam Impurity 66 |
|
|
 |
2-Acetoxymethyl1-3-Methyl-4- |
112525-75-4 |
C11H12F3NO3 |
 |
Ertapenem Impurity D(USP) |
|
|
 |
3-(N-Benzyl-N-methylamino)propiophenone hydrochloride |
5409-62-1 |
C17H20ClNO |
![2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-4-hydroxy-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester, (1S,4S)-](/CAS/20210305/GIF/869884-24-2.gif) |
2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-4-hydroxy-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester, (1S,4S)- |
869884-24-2 |
C23H26N2O3 |
 |
Azilsartan Medoxomil Potassium impurity209 |
|
|
 |
Nelarabine impurity 01 |
|
|
 |
Cyclopropanamine, 2-(3-fluorophenyl)-, (1R,2S)- (9CI) |
220353-83-3 |
C9H10FN |
![1(2H)-Naphthalenone, 4-hydroxy-3-methyl-2-[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraen-1-ylidene]-](/CAS/20210305/GIF/693781-59-8.gif) |
1(2H)-Naphthalenone, 4-hydroxy-3-methyl-2-[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraen-1-ylidene]- |
693781-59-8 |
C31H40O2 |
 |
Bisoprolol Impurity 50 |
|
|
 |
Milnacipran Impurity 26 |
|
|
 |
Olodaterol Impurity 15 |
|
|
![2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylthio)phenyl]-, hydrochloride (1:1)](/CAS/20211123/GIF/1447814-82-5.gif) |
2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylthio)phenyl]-, hydrochloride (1:1) |
1447814-82-5 |
C18H16Cl2N2S |
 |
Pitavastatin Impurity 104 |
|
|
 |
Tegoprazan Impurity 8 |
|
|
 |
Atomoxetine EP Impurity G DiHCl (Mixture of Diastereomers) |
2706536-33-4 |
C27H34N2O2 |
 |
Nirmatrelvir Impurity 10 |
|
|
 |
Levosimendan Nitrosogenin Impurities |
|
|
 |
7-ブロモアセチルアミノセファロスポラン酸 |
26973-80-8 |
C12H13BrN2O6S |
 |
Bumetanide Impurity 20 |
|
|
 |
Rocuronium Bromide Impurity 28 、29 |
|
|
 |
Roxadustat Impurity 22 |
|
|
 |
Olaparib Impurity 41 |
|
|
 |
Perospirone Impurity 22 |
|
|
 |
Perospirone Impurity 14 |
87691-94-9 |
C15H20BrN3S |
 |
Dolutegravir Impurity 22 |
|
|
 |
Paxlovid Impurity 20 |
|
|
 |
Related impurities 7 of fluoxetine sodium |
|
|
 |
Revefenacin Impurity 16 |
|
|
 |
Fondaparinux sodium impurity 8 |
|
|
 |
Fondaparinux sodium impurity 14 |
|
|
 |
Fondaparinux Sodium Impurity 9 |
|
|
 |
Oxacillin sodium Impurity D |
|
|
 |
Piracetam IMPURITY |
|
|
 |
Nilotinib N-Oxide Impurity 4 |
|
|
![sodium (6R,7S)-7-amino-7-methoxy-6-methyl-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](/) |
sodium (6R,7S)-7-amino-7-methoxy-6-methyl-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
 |
Olodaterol Impurity 32 |
|
|
 |
(R)-Lercanidipine Hydrochloride |
187731-34-6 |
C36H42ClN3O6 |
 |
2-Oxo Clopidogrel Hydrochloride(Mixture of diastereomers) |
109904-27-0 |
C16H16ClNO3S |
 |
5-ヒドロキシ-6-メトキシ-1-インダノン |
127399-78-4 |
C10H10O3 |
 |
Desfluoro Citalopram Oxalate |
1093072-86-6 |
C22H24N2O5 |
 |
Didesmethyl Zolmitriptan |
139264-15-6 |
C14H17N3O2 |
 |
1-(カルボキシメチル)シクロヘキサン-1-カルボン酸 |
67950-95-2 |
C9H14O4 |
 |
ヒドロキシボセンタン |
253688-60-7 |
C27H29N5O7S |
![LISINOPRIL RELATED COMPOUND A ((S)-2-{(3S,8AS)-3-(4-AMINOBUTYL)-1,4-DIOXOHEXAHYDROPYRROLO[1,2-A]PYRAZIN-2(1H)-YL}-4-PHENYLBUTANOIC ACID)](/CAS/GIF/328385-86-0.gif) |
LISINOPRIL RELATED COMPOUND A ((S)-2-{(3S,8AS)-3-(4-AMINOBUTYL)-1,4-DIOXOHEXAHYDROPYRROLO[1,2-A]PYRAZIN-2(1H)-YL}-4-PHENYLBUTANOIC ACID) |
328385-86-0 |
C21H29N3O4 |
 |
trans 1-Benzyl-4-(4-fluorophenyl)-3-piperidinemethanol |
201855-60-9 |
C19H22FNO |
 |
1-エチル-4-オキソ-6-フルオロ-7-クロロ-1,4-ジヒドロキノリン-3-カルボン酸エチル |
70458-94-5 |
C14H13ClFNO3 |
 |
Capecitabine Related Compound B |
|
|
 |
D-erythro-3,4-Dihydroxyphenylserine |
51829-98-2 |
C9H11NO5 |
![5H-[1]Benzopyrano[2,3-b]pyridine,7-ethyl-(9CI)](/CAS/20200515/GIF/639857-68-4.gif) |
5H-[1]Benzopyrano[2,3-b]pyridine,7-ethyl-(9CI) |
639857-68-4 |
C14H13NO |
 |
ヘキサヒドロキシビフェニル |
76625-61-1 |
C12H10O6 |
 |
lamivudine sulfoxide |
160552-55-6 |
C8H11N3O4S |
 |
Vitamin B12 e-Monocarboxylic Acid |
26264-28-8 |
C63H87CoN13O15P |
 |
カフェイジン |
20041-90-1 |
C7H12N4O |
 |
メトレレプチン(遺伝子組換え) |
186018-45-1 |
|
 |
3,5-ジヨード-4-(4-ヒドロキシ-3,5-ジヨードフェノキシ)安息香酸 |
2055-97-2 |
C13H6I4O4 |
![SOTALOL RELATED COMPOUND C (N-[4-[2-[(1-メチルエチル)アミノ]エチル]フェニル]メタンスルホンアミド MONOHYDROCHLORIDE)](/CAS/GIF/16974-42-8.gif) |
SOTALOL RELATED COMPOUND C (N-[4-[2-[(1-メチルエチル)アミノ]エチル]フェニル]メタンスルホンアミド MONOHYDROCHLORIDE) |
16974-42-8 |
C12H20N2O2S |
![3β-[(2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル)オキシ]-12β,14-ジヒドロキシ-5β,14β-カルダ-20(22)-エノリド](/CAS/GIF/5352-63-6.gif) |
3β-[(2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル)オキシ]-12β,14-ジヒドロキシ-5β,14β-カルダ-20(22)-エノリド |
5352-63-6 |
C29H44O8 |
 |
2-(ジメチルアミノ)-N-(2,6-ジメチルフェニル)アセトアミド |
21236-54-4 |
C12H18N2O |